India – Dr Reddy’s to seek approval for Sputnik V jab by March

Dr Reddy’s Laboratories expects to complete phase-3 clinical trials of Russia’s Sputnik V Covid-19 vaccine in India by February-end and seek emergency authorisation for use in the country by March.

The Indian study of Sputnik V, a bridging phase-2/3 trial on 1,600 participants to assess immunogenicity and safety, was progressing well, Deepak Sapra, Dr Reddy’s chief executive for active pharmaceutical ingredients and pharmaceutical services, told the media on Friday…